Acute myeloid leukemia in the elderly (age 70 yr or older): long-term survivors.

about

Acute myeloid leukemia in the elderly (age 70 yr or older): long-term survivors.

Item

http://www.wikidata.org/entity/Q39311595

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Acute myeloid leukemia in the elderly (age 70 yr or older): long-term survivors.

@en

Acute myeloid leukemia in the elderly

@nl

type

Item

label

Acute myeloid leukemia in the elderly (age 70 yr or older): long-term survivors.

@en

Acute myeloid leukemia in the elderly

@nl

prefLabel

Acute myeloid leukemia in the elderly (age 70 yr or older): long-term survivors.

@en

Acute myeloid leukemia in the elderly

@nl

P1476

Acute myeloid leukemia in the elderly (age 70 yr or older): long-term survivors

@en

P2093

Alexandre Deloire

http://www.w3.org/2001/XMLSchema#string

Caroline Le Jeune

http://www.w3.org/2001/XMLSchema#string

Eric Wattel

http://www.w3.org/2001/XMLSchema#string

Gilles Salles

http://www.w3.org/2001/XMLSchema#string

Marie-Charlotte Laude

http://www.w3.org/2001/XMLSchema#string

Mohamed Elhamri

http://www.w3.org/2001/XMLSchema#string

Xavier Thomas

http://www.w3.org/2001/XMLSchema#string

P2860

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

Outcome of older patients with acute myeloid leukemia: an analysis of SEER data over 3 decades.

A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial

Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry.

Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study.

Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia.

Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience.

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial.

P304

134-141

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/EJH.12811

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maël Heiblig

P577

2016-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27717105

http://www.w3.org/2001/XMLSchema#string

P921

leukemia